Skip to main content
Equibles

PNC FINANCIAL SERVICES GROUP, INC.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 713676 Pittsburgh, PA
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,910,823
+$530,671 QoQ
Shares Held
131,872
+32.3% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $41,251,853 across 44 Drug Manufacturers - Specialty & Generic names. RDY ranks #7 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 179,533 $12,901,240
2 VTRS
Viatris Inc
 473,597 $7,520,716
3 TEVA
Teva Pharmaceutical Industries Ltd
 111,150 $3,765,760
4 HIMS
Hims & Hers Health, Inc.
 71,535 $2,480,117
5 UTHR
UNITED THERAPEUTICS Corp
 4,304 $2,332,032
6 HLN
Haleon plc
 235,375 $2,196,046
7 RDY
Dr Reddys Laboratories Ltd
This page 		131,872 $1,910,823
8 NBIX
Neurocrine Biosciences Inc
 6,337 $1,068,033

All Filings in RDY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,910,823 131,872
2026-03-31 $1,380,152 99,650
2025-12-31 $1,108,048 78,921
2025-09-30 $907,580 64,920
2025-06-30 $718,566 47,809
2025-03-31 $524,208 39,743
2024-12-31 $610,186 38,644
2024-09-30 $608,108 7,654
2024-06-30 $583,003 7,652
2024-03-31 $548,362 7,476
2023-12-31 $518,856 7,457
2023-09-30 $499,649 7,472
2023-06-30 $513,019 8,129
2023-03-31 $396,515 6,965
2022-12-31 $314,793 6,083
2022-09-30 $308,960 5,903
2022-06-30 $258,447 4,666
2022-03-31 $237,799 4,267
2021-12-31 $274,981 4,204
2021-09-30 $257,107 3,947
2021-06-30 $273,823 3,725
2021-03-31 $293,013 4,773
2020-12-31 $340,051 4,770
2020-09-30 $345,641 4,969
2020-06-30 $261,020 4,924
2020-03-31 $212,295 5,264